GI Dynamics Inc (GIDYL) Financial Statements (2023 and Earlier)
Company Profile
| Business Address |
320 CONGRESS STREET BOSTON, MA 02210 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 931 | 1,159 | 2,675 | 733 | 3,854 | 2,499 | ||
| Cash and cash equivalents | 931 | 1,159 | 2,675 | 733 | 3,854 | 2,499 | ||
| Prepaid expense | 3,029 | 3,292 | ||||||
| Other current assets | 2,628 | 156 | ||||||
| Other undisclosed current assets | 30 | 30 | 30 | 3,728 | 1,407 | 1,260 | ||
| Total current assets: | 3,589 | 4,218 | 6,153 | 4,461 | 5,261 | 3,759 | ||
| Noncurrent Assets | ||||||||
| Operating lease, right-of-use asset | 206 | 244 | 281 | 316 | 352 | 386 | ||
| Property, plant and equipment | 9 | 14 | 20 | 27 | 34 | 42 | ||
| Total noncurrent assets: | 215 | 258 | 301 | 343 | 386 | 428 | ||
| TOTAL ASSETS: | 3,804 | 4,476 | 6,454 | 4,804 | 5,647 | 4,187 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 915 | 1,013 | 1,089 | 2,131 | 1,407 | 1,989 | ||
| Accounts payable | 249 | 430 | 258 | 901 | 521 | 636 | ||
| Accrued liabilities | 666 | 583 | 831 | 1,230 | 886 | 1,353 | ||
| Debt | 222 | 263 | 318 | 195 | 5,170 | 5,169 | ||
| Derivative instruments and hedges, liabilities | 10 | |||||||
| Other undisclosed current liabilities | 172 | 172 | 171 | 5,955 | ||||
| Total current liabilities: | 1,309 | 1,448 | 1,578 | 8,281 | 6,577 | 7,168 | ||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 3,753 | 3,563 | 3,308 | 2,233 | 2,132 | 217 | ||
| Long-term debt, excluding current maturities | 3,726 | 3,496 | 3,202 | 2,088 | 1,950 | |||
| Operating lease, liability | 27 | 67 | 106 | 145 | 182 | 217 | ||
| Other undisclosed noncurrent liabilities | (27) | (67) | (106) | (145) | ||||
| Total noncurrent liabilities: | 3,753 | 3,496 | 3,308 | 2,233 | 2,132 | 217 | ||
| Total liabilities: | 5,062 | 5,011 | 4,886 | 10,514 | 8,709 | 7,385 | ||
| Temporary equity, carrying amount | 5,325 | |||||||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent | (1,258) | (535) | (3,757) | (5,710) | (3,062) | (3,198) | ||
| Preferred stock | 776 | 601 | ||||||
| Common stock | 881 | 881 | 881 | 366 | 366 | 366 | ||
| Additional paid in capital | 295,082 | 293,611 | 289,162 | 284,089 | 283,905 | 280,928 | ||
| Accumulated deficit | (297,997) | (295,628) | (293,800) | (290,165) | (287,333) | (284,492) | ||
| Total stockholders' equity: | (1,258) | (535) | (3,757) | (5,710) | (3,062) | (3,198) | ||
| TOTAL LIABILITIES AND EQUITY: | 3,804 | 4,476 | 6,454 | 4,804 | 5,647 | 4,187 | ||
Income Statement (P&L) ($ in thousands)
| 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | ||
|---|---|---|---|---|---|---|---|
| Operating expenses | (2,072) | (1,454) | (2,449) | (2,486) | (2,716) | (2,512) | |
| Operating loss: | (2,072) | (1,454) | (2,449) | (2,486) | (2,716) | (2,512) | |
| Nonoperating income (expense) | (297) | (365) | (1,181) | (341) | (120) | 15,536 | |
| Interest and debt expense | (292) | (678) | (352) | (284) | 20 | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (2,661) | (1,819) | (4,308) | (3,179) | (3,120) | 13,044 | |
| Other undisclosed income (loss) from continuing operations before income taxes | 292 | 678 | 352 | 284 | (15,512) | ||
| Loss from continuing operations before income taxes: | (2,369) | (1,819) | (3,630) | (2,827) | (2,836) | (2,468) | |
| Income tax expense | (9) | (5) | (5) | (5) | (13) | ||
| Net loss available to common stockholders, diluted: | (2,369) | (1,828) | (3,635) | (2,832) | (2,841) | (2,481) | |
Comprehensive Income ($ in thousands)
| 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | 12/31/2019 Q4 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (2,369) | (1,828) | (3,635) | (2,832) | (2,841) | (2,481) | |
| Comprehensive loss, net of tax, attributable to parent: | (2,369) | (1,828) | (3,635) | (2,832) | (2,841) | (2,481) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.